Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Prevention trials

Topic: Risk, prevention and care in population studies

Plain-language summary

Introduction Establishing a nationwide prevention programme can be challenging, particularly in the field of dementia, as role model projects are lacking, and the topic is still associated with stigma. Hence, a satisfaction survey for the programme dementia prevention ( pdp ) in Luxembourg was conducted to obtain direct feedback from the participants on how the programme and its multidomain interventions are accepted and evaluated. Methods In 2023 and 2024, a satisfaction survey was sent out to all eligible pdp participants (n = 575). Participation was voluntary and anonymous, and the survey could be completed in paper form or online. The questionnaire contained 12 closed-ended questions rated on a Likert-scale and 3 open questions. Results 302 (52.5%) participants returned the survey. The analysis revealed a high level of satisfaction with an overall average satisfaction of 4.7/5 points (SD = 0.6). 281 participants (95.9%) would recommend the pdp to others. A breakdown of the statements provided insights into areas of interest from the participants’ perspective. Discussion Our study shows that the pdp is well received by its participants, underlined by a high level of satisfaction and positive responses to what pdp offers. Findings showed that interactions were perceived as informative to gain insights into one’s own cognitive performance and raised awareness of possibilities to reduce dementia risk, i.e., via lifestyle changes. Our results can serve as orientation for the implementation of emerging prevention programmes in different healthcare settings.

What this study adds

Evidence grade: Low

The record lists 575 participants. This satisfaction survey found that participants in a dementia prevention programme in Luxembourg reported high satisfaction and would recommend it to others. Reported effect size: 52.5%; 95.9%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Erz, D., Schröder, V. E., Skrozic, A., Loureiro, J. M., Possemis, N., & Krüger, R. (2026). Dementia prevention through the eyes of individuals at risk: insights from a satisfaction survey within the programme for dementia prevention in Luxembourg. Frontiers in Aging. https://doi.org/10.3389/fragi.2026.1712500

Vancouver

Erz D, Schröder VE, Skrozic A, Loureiro JM, Possemis N, Krüger R. Dementia prevention through the eyes of individuals at risk: insights from a satisfaction survey within the programme for dementia prevention in Luxembourg. Frontiers in Aging. 2026. doi:10.3389/fragi.2026.1712500. PMID: 41624994.

BibTeX

@article{erz2026-41624994,
  author  = {Erz, Dorothee and Schröder, Valerie E. and Skrozic, Amna and Loureiro, João Mimoso and Possemis, Nina and Krüger, Rejko},
  title   = {{Dementia prevention through the eyes of individuals at risk: insights from a satisfaction survey within the programme for dementia prevention in Luxembourg}},
  journal = {Frontiers in Aging},
  year    = {2026},
  doi     = {10.3389/fragi.2026.1712500},
  pmid    = {41624994},
  url     = {https://doi.org/10.3389/fragi.2026.1712500}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This satisfaction survey found that participants in a dementia prevention programme in Luxembourg reported high satisfaction and would recommend it to others. It measures how the programme is received, not whether it treats, cures or prevents Alzheimer's disease.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 2 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 0 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 43 of 100.43 of 100 points earned57 not earned

Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Frontiers in Aging)
Journal's citation record 0 / 4 Frontiers in Aging: journal h-index 43 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 2 / 4 575 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 4.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Rejko Krüger: h-index 72 (OpenAlex, whole career)
Institution's track record 0 / 3 University of Luxembourg: institution h-index 404 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41624994)
Free to read 2 / 2 Free to read
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Prevention trials from nearby years

Also tagged “prevalence”

1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Prevention trials

See all studies in Prevention trials →